In LUSC and BLCA, ESPL1 was also positively correlated with MATH, HRD, and all the four indicators suggesting that target ESPL1-targeted treatments may be effective in LUSC and BLCA. The gene discussed is ESPL1; the disease is bladder transitional cell carcinoma.